Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Liver Transpl. 2019 Nov 20;26(3):349–358. doi: 10.1002/lt.25662

Table 3.

Cox regression analysis for post-liver transplantation mortality among all patients listed for liver transplant

Univariable Multivariable*

HR 95% CI P value HR 95% CI P value

Age ≥65 (at listing) 1.39 1.33–1.45 <0.001 1.50 1.41 – 1.60 <0.001
HCC 1.13 1.09–1.18 <0.001 1.26 1.18 – 1.33 <0.001
Female gender 0.93 0.90–0.96 <0.001
Liver diagnosis
Alcohol Ref Ref
Hepatitis C 1.26 1.21–1.32 <0.001 1.34 1.28 – 1.40 <0.001
NASH 1.06 1.01–1.12 0.02 1.07 1.01 – 1.12 0.02
Autoimmune 0.81 0.77–0.86 <0.001 0.87 0.81 – 0.93 <0.001
Other 1.10 1.02–1.17 0.007 1.11 1.04 – 1.18 0.001
MELD (final) per point 1.01 1.01–1.01 <0.001 1.01 1.01 – 1.02 <0.001
Waiting List Time per 90 days 0.99 0.98 – 0.99 <0.001 0.99 0.98 – 0.997 0.03
KPS per 10 points 1.00 0.00–1.00 <0.001 0.96 0.95 – 0.97 <0.001
Hepatic encephalopathy 1.21 1.16–1.26 <0.001 1.11 1.05 – 1.18 <0.001
Donor risk index per 0.1 points 1.38 1.30–1.47 <0.001 1.03 1.03 – 1.04 <0.001

HR, hazard ratio; CI, confidence interval; HCC, hepatocellular carcinoma; NASH, nonalcoholic steatohepatitis; MELD, model for end stage liver disease; KPS, Karnofsky Performance Status

*

Multivariable model also adjusted for interaction term between age and HCC